ABCB1 C3435T Polymorphism Influences the Risk for Alzheimer’s Disease

Journal of Molecular Neuroscience

Volumn 54, Issue 4, 2014, Pages 826-829

  Fehér, Ágnes ^a   Juhász, Anna ^a   Pákáski, Magdolna ^a   Kálmán, János ^a   Janka, Zoltán ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer s disease; ATP binding cassette subfamily B member 1 (ABCB1); P glycoprotein (P gp); rs1045642 (C3435T); rs1128503 (C1236T); rs2032582 (G2677T A); Single nucleotide polymorphism (SNP)

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT RISK; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENETICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; P-GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84914117900     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0427-z     Document Type: Article

References (26)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
2. Cascorbi I, Flüh C, Remmler C et al (2013) Association of ATP-binding cassette transporter variants with the risk of Alzheimer’s disease. Pharmacogenomics 14:485–494
3. Cascorbi I, Gerloff T, Johne A et al (2004) Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 69:169–174
4. Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, Wang PN (2011) Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer’s disease. Neurobiol Dis 43:698–705
5. Cirrito JR, Deane R, Fagan AM et al (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer’s disease mouse model. J Clin Invest 115:3285–3290
6. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates Inc., Hillsdale, New Jersey, pp 216–226
7. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191
8. Frankfort SV, Doodeman VD, Bakker R et al (2006) ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients. Mol Neurodegener 1:13
9. Frankfort SV, van Campen JP, Tulner LR, Beijnen JH (2008) Serum amyloid beta peptides in patients with dementia and age-matched non-demented controls as detected by surface-enhanced laser desorption ionisation-time of flight mass spectrometry (SELDI-TOF MS). Curr Clin Pharmacol 3:144–154
10. Hoffmeyer S, Burk O, von Richter O et al (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97:3473–3478
11. Jeynes B, Provias J (2011) An investigation into the role of P-glycoprotein in Alzheimer’s disease lesion pathogenesis. Neurosci Lett 487:389–393
12. Kohen R, Shofer JB, Korvatska O et al (2011) ABCB1 genotype and CSF beta-amyloid in Alzheimer disease. J Geriatr Psychiatry Neurol 24:63–66
13. Kuhnke D, Jedlitschky G, Grube M et al (2007) MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer’s amyloid-beta peptides—implications for the mechanisms of beta-amyloid clearance at the blood-brain barrier. Brain Pathol 17:347–353
14. Lam FC, Liu R, Lu P et al (2001) Beta-amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121–1128
15. Li H, Wetten S, Li L et al (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65:45–53
16. Mawuenyega KG, Sigurdson W, Ovod V et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330:1774
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944
18. Nakamura T, Sakaeda T, Horinouchi M et al (2002) Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 71:297–303
19. Pahnke J, Wolkenhauer O, Krohn MA, Walker LC (2008) Clinico-pathologic function of cerebral ABC transporters—implications for the pathogenesis of Alzheimer’s disease. Curr Alzheimer Res 5:396–405
20. Reiman EM, Webster JA, Myers AJ et al (2007) GAB2 alleles modify Alzheimer’s risk in APOE epsilon4 carriers. Neuron 54:713–720
21. Sakaeda T, Nakamura T, Horinouchi M et al (2001) MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm Res 18:1400–1404
22. Sipeky C, Csongei V, Jaromi L et al (2011) Genetic variability and haplotype profile of MDR1 (ABCB1) in Roma and Hungarian population samples with a review of the literature. Drug Metab Pharmacokinet 26:206–215
23. Van Assema DME, Lubberink M, Rizzu P et al. (2012) Blood–brain barrier P-glycoprotein function in healthy subjects and Alzheimer’s disease patients: effect of polymorphisms in the ABCB1 gene
24. Vogelgesang S, Cascorbi I, Schroeder E et al (2002) Deposition of Alzheimer’s beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12:535–541
25. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W (2005) Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C > T affects mRNA stability. Pharmacogenet Genomics 15:693–704
26. Wolf A, Bauer B, Hartz AM (2012) ABC transporters and the Alzheimer’s disease enigma. Front Psychiatry 3:54